Company profile
Psyence Biomedical Ltd.
NASDAQ: PBM · Healthcare · Biotechnology
Canadian filerHQ Toronto, ONCIK 0001985062Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 21
v0.1 · 5/100 weight · pillars only
↑ balance-sheet leverage, return on assets · ↓ filing timeliness, listing tenure
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
$1.0M
Employees
12
as of 2026-08-28
Market cap
$79.9k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income$1.0M$1.0M2025
Total assets$7.3M$7.3M2025
Liabilities$594.4k$594.4k2025
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Psyence Biomedical Ltd.’s financial profile?
Psyence Biomedical Ltd. earned $1.0M in FY2025 net income.
Peers · Healthcare
MedGen, Inc.——Mobile Lads Corp.——Lotus Pharmaceuticals, Inc.——Indocan Resources Inc.——Patient Access Solutions, Inc.——Vincerx Pharma, Inc.——Key facts
CEOJody Aufrichtig
SectorHealthcare
IndustryBiotechnology
HeadquartersToronto, ON
ExchangeNASDAQ: PBM
Employees12
IPO date2021-12-10
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.